Skip to main content

Press releases | March 2, 2020

Fried Frank acted as counsel to Catalent, Inc. in connection with the issuance of €825 million aggregate principal amount of 2.375% senior notes due 2028. The net proceeds were used to redeem in full its euro-denominated 4.750% senior notes due 2024, repay all outstanding euro-denominated term loans under its senior secured credit facilities, pay related fees and expenses, and provide cash on its balance sheet for general corporate purposes, including capital expenditures. Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.   

The Fried Frank team was led by corporate partners Daniel J. Bursky and Joshua T. Coleman and included tax partner Michael J. Alter; corporate associates Danica E. Curavic, Matthew R. Friedman, and Charles Stern; and tax associate Ryan L. Conley.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.